Nutriband Inc. Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NTRBW Company Description
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
NTRBW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NTRBW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NTRBW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NTRBW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of NTRBW in WallStreetBets Daily Discussion
NTRBW News
Recent insights relating to NTRBW
CNBC Recommendations
Recent picks made for NTRBW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NTRBW
Corporate Flights
Flights by private jets registered to NTRBW
Our Analysis